These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

778 related items for PubMed ID: 18787045

  • 1. Plasma 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D, and parathyroid hormone in familial hypocalciuric hypercalcemia and primary hyperparathyroidism.
    Christensen SE, Nissen PH, Vestergaard P, Heickendorff L, Rejnmark L, Brixen K, Mosekilde L.
    Eur J Endocrinol; 2008 Dec; 159(6):719-27. PubMed ID: 18787045
    [Abstract] [Full Text] [Related]

  • 2. Familial Hypocalciuric Hypercalcemia Types 1 and 3 and Primary Hyperparathyroidism: Similarities and Differences.
    Vargas-Poussou R, Mansour-Hendili L, Baron S, Bertocchio JP, Travers C, Simian C, Treard C, Baudouin V, Beltran S, Broux F, Camard O, Cloarec S, Cormier C, Debussche X, Dubosclard E, Eid C, Haymann JP, Kiando SR, Kuhn JM, Lefort G, Linglart A, Lucas-Pouliquen B, Macher MA, Maruani G, Ouzounian S, Polak M, Requeda E, Robier D, Silve C, Souberbielle JC, Tack I, Vezzosi D, Jeunemaitre X, Houillier P.
    J Clin Endocrinol Metab; 2016 May; 101(5):2185-95. PubMed ID: 26963950
    [Abstract] [Full Text] [Related]

  • 3. Calcium-sensing-related gene mutations in hypercalcaemic hypocalciuric patients as differential diagnosis from primary hyperparathyroidism: detection of two novel inactivating mutations in an Italian population.
    Stratta P, Merlotti G, Musetti C, Quaglia M, Pagani A, Izzo C, Radin E, Airoldi A, Baorda F, Palladino T, Leone MP, Guarnieri V.
    Nephrol Dial Transplant; 2014 Oct; 29(10):1902-9. PubMed ID: 25104082
    [Abstract] [Full Text] [Related]

  • 4. Forearm bone mineral density in familial hypocalciuric hypercalcemia and primary hyperparathyroidism: a comparative study.
    Isaksen T, Nielsen CS, Christensen SE, Nissen PH, Heickendorff L, Mosekilde L.
    Calcif Tissue Int; 2011 Oct; 89(4):285-94. PubMed ID: 21785908
    [Abstract] [Full Text] [Related]

  • 5. Familial hypocalciuric hypercalcemia in an index male: grey zones of the differential diagnosis from primary hyperparathyroidism in a 13-year clinical follow up.
    Zajíčková K, Dvořáková M, Moravcová J, Včelák J, Goltzman D.
    Physiol Res; 2020 Sep 30; 69(Suppl 2):S321-S328. PubMed ID: 33094630
    [Abstract] [Full Text] [Related]

  • 6. Skeletal consequences of familial hypocalciuric hypercalcaemia vs. primary hyperparathyroidism.
    Christensen SE, Nissen PH, Vestergaard P, Heickendorff L, Rejnmark L, Brixen K, Mosekilde L.
    Clin Endocrinol (Oxf); 2009 Dec 30; 71(6):798-807. PubMed ID: 19250271
    [Abstract] [Full Text] [Related]

  • 7. Familial Hypocalciuric Hypercalcemia as an Atypical Form of Primary Hyperparathyroidism.
    Marx SJ.
    J Bone Miner Res; 2018 Jan 30; 33(1):27-31. PubMed ID: 29115694
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Persistent hypercalcemia with similar familial Hypocalciuric hypercalcemia features: a case report and literature review.
    Zahedi M, Hizomi Arani R, Rafati M, Amouzegar A, Hadaegh F.
    BMC Endocr Disord; 2021 Nov 04; 21(1):220. PubMed ID: 34736428
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Familial hypocalciuric hypercalcaemia: a review.
    Christensen SE, Nissen PH, Vestergaard P, Mosekilde L.
    Curr Opin Endocrinol Diabetes Obes; 2011 Dec 04; 18(6):359-70. PubMed ID: 21986511
    [Abstract] [Full Text] [Related]

  • 13. Parathyroid hormone-dependent familial hypercalcemia with low measured PTH levels and a presumptive novel pathogenic mutation in CaSR.
    Mahajan A, Buse J, Kline G.
    Osteoporos Int; 2020 Jan 04; 31(1):203-207. PubMed ID: 31641801
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Muscle function and quality of life are not impaired in familial hypocalciuric hypercalcemia: a cross-sectional study on physiological effects of inactivating variants in the calcium-sensing receptor gene (CASR).
    Jakobsen NF, Rolighed L, Nissen PH, Mosekilde L, Rejnmark L.
    Eur J Endocrinol; 2013 Sep 04; 169(3):349-57. PubMed ID: 23764372
    [Abstract] [Full Text] [Related]

  • 17. Concomitant familial hypocalciuric hypercalcemia and single parathyroid adenoma: a case report.
    Marstrand SD, Tofteng CL, Jarløv A, Borgwardt L, Schwarz P.
    J Med Case Rep; 2021 Sep 24; 15(1):471. PubMed ID: 34556169
    [Abstract] [Full Text] [Related]

  • 18. Differentiating familial hypocalciuric hypercalcemia from primary hyperparathyroidism.
    Shinall MC, Dahir KM, Broome JT.
    Endocr Pract; 2013 Sep 24; 19(4):697-702. PubMed ID: 23425644
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Identification and functional characterization of a novel mutation in the calcium-sensing receptor gene in familial hypocalciuric hypercalcemia: modulation of clinical severity by vitamin D status.
    Zajickova K, Vrbikova J, Canaff L, Pawelek PD, Goltzman D, Hendy GN.
    J Clin Endocrinol Metab; 2007 Jul 24; 92(7):2616-23. PubMed ID: 17473068
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 39.